PATENT CLAIM ANALYSIS

Application Number: 15994934
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "04400A"]

Abstract:
The present invention relates to a method for treating degenerative neurological disorders in a subject in need thereof, comprising administering to a subject in need thereof a therapeutically effective amount of a composition comprising an acid sphingomyelinase (ASM) activity inhibitor or expression inhibitor as an active ingredient.

Claim (Index 1):
A method for treating a degenerative neurological disorder in a subject in need thereof, comprising administering to a subject a therapeutically effective amount of a composition comprising an acid sphingomyelinase (ASM) activity inhibitor or expression inhibitor as an active ingredient.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 93.0
- Lexical Diversity: 1.34211
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14889293', '15417315', '15313642', '14550025', '14289996']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7337145285056441
- 35 USC 102 Novelty (BERT): 0.5932305952729156
- Combined Prediction Score: 0.7196661351823713
- Mean Citation Score: 350.576054
- Max Citation Score: 522.7991
- Similarity Product: 419.8126179792464

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test